Please Wait
Applying Filters...
menu
    • menu
    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Sebetralstat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KalVista’s Ekterly Gets UK Nod for Hereditary Angioedema
    KalVista’s Ekterly Gets UK Nod for Hereditary Angioedema

    15 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250715103754/en/KalVista-Pharmaceuticals-Announces-UK-MHRA-Approval-of-EKTERLY-sebetralstat-First-and-Only-Oral-On-demand-Treatment-for-Hereditary-Angioedema

    BUSINESSWIRE
    15 Jul 2025
    Share Share
    Kal Vista Pharmaceuticals Updates Operations, Reports Fiscal Year
    Kal Vista Pharmaceuticals Updates Operations, Reports Fiscal Year

    10 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250710831184/en/KalVista-Pharmaceuticals-Provides-Operational-Update-and-Fiscal-Year-2025-Financial-Results

    BUSINESSWIRE
    10 Jul 2025
    Share Share
    US FDA Approves KalVista Pharma's Swelling Disorder Drug
    US FDA Approves KalVista Pharma's Swelling Disorder Drug

    07 Jul 2025

    // PRESS RELEASE

    https://ir.kalvista.com/news-releases/news-release-details/kalvista-pharmaceuticals-announces-fda-approval-ekterlyr

    PRESS RELEASE
    07 Jul 2025
    Share Share
    Orsini to Partner as Specialty Pharmacy for KalVista's Ekterly
    Orsini to Partner as Specialty Pharmacy for KalVista's Ekterly

    07 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orsini-selected-as-specialty-pharmacy-partner-for-kalvistas-ekterly-sebetralstat-302498995.html

    PR NEWSWIRE
    07 Jul 2025
    Share Share
    KalVista & Pendopharm Ink Deal for Sebetralstat in Canada
    KalVista & Pendopharm Ink Deal for Sebetralstat in Canada

    26 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250626645779/en/KalVista-Pharmaceuticals-Enters-into-Licensing-Agreement-with-Pendopharm-to-Commercialize-Sebetralstat-for-HAE-in-Canada

    BUSINESSWIRE
    26 Jun 2025
    Share Share
    FDA Delays Sebetralstat NDA Due to Staffing Limits
    FDA Delays Sebetralstat NDA Due to Staffing Limits

    13 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250613608281/en/KalVista-Pharmaceuticals-Announces-FDA-Will-Not-Meet-PDUFA-Goal-Date-for-Sebetralstat-NDA-for-Hereditary-Angioedema-Due-to-FDA-Resource-Constraints

    BUSINESSWIRE
    13 Jun 2025
    Share Share